Exploring The Diverse Therapeutic Potentials of Synthetic Analogues of Keto-terpenoids (+) Carvone: A Future Scaffold
CONCLUSION: S(+) carvone has a CNS depressive impact and possesses an anti-convulsant activity. According to the research parameters on both the enantiomers, R&S can block GABA binding sites. Therefore, it suggests that S(+) carvone may be the new moiety for anticonvulsant activity. It has been observed by various studies that the S(+) carvone is more powerful than R(-) carvone. Therefore, it can be concluded that S(+) Carvone can serve as a scaffold for anticonvulsant activity.PMID:38551059 | DOI:10.2174/0118715249278766240322054108
Source: Molecular Medicine - Category: Molecular Biology Authors: Snigdha Srivastava Reema Sinha Rahul Kaushik Rajan Kumar Kurmi Source Type: research
More News: Antidoxidants | Brain | Brain Cancers | Cancer | Cancer & Oncology | Caraway | Chemistry | Depression | Dyspepsia | Epilepsy | Gastric (Stomach) Cancer | Gastroenterology | Headache | Indigestion | Liver | Melanoma | Molecular Biology | Neurology | Rheumatology | Skin | Skin Cancer | Study | Toxicology | Urology & Nephrology